Dr. Suparna Mantha
Claim this profileCarle Cancer Center
Studies Cancer
Studies Adenocarcinoma
34 reported clinical trials
77 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
BRAF negative
2Adenocarcinoma
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Suparna Mantha is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting1 award Phase 27 criteria
More about Suparna Mantha
Clinical Trial Related4 years of experience running clinical trials · Led 34 trials as a Principal Investigator · 24 Active Clinical TrialsTreatments Suparna Mantha has experience with
- Atezolizumab
- Fluorouracil
- Venetoclax
- Bevacizumab
- Nivolumab
- Cisplatin
Breakdown of trials Suparna Mantha has run
Cancer
Adenocarcinoma
Colorectal Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suparna Mantha specialize in?
Suparna Mantha focuses on Cancer and Adenocarcinoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Suparna Mantha currently recruiting for clinical trials?
Yes, Suparna Mantha is currently recruiting for 21 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Suparna Mantha has studied deeply?
Yes, Suparna Mantha has studied treatments such as Atezolizumab, Fluorouracil, Venetoclax.
What is the best way to schedule an appointment with Suparna Mantha?
Apply for one of the trials that Suparna Mantha is conducting.
What is the office address of Suparna Mantha?
The office of Suparna Mantha is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.